Mouse Models of Insulin Resistance

Physiological Reviews

Volumn 84, Issue 2, 2004, Pages 623-647

  Nandi, Anindita ^b   Kitamura, Yukari ^b   Kahn, C Ronald ^b   Accili, Domenico ^a  

^a Berrie Research Pavilion   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BREEDING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPERTENSION; HYPOTHESIS; INSULIN RESISTANCE; MOUSE; MUTAGENESIS; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSGENICS;

ANIMALS; DISEASE MODELS, ANIMAL; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; RECEPTOR, INSULIN;

EID: 1642370615     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00032.2003     Document Type: Review

References (254)

1. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, and Kahn BB. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104: 1703-1714, 1999.
2. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, and Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733, 2001.
3. Accili D. A kinase in the life of the beta cell. J Clin Invest 108: 1575-1576, 2001.
4. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, and Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12: 106-109, 1996.
5. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
6. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, and White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531-1537, 2002.
7. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, and Bownes M. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7: 776-789, 1997.
8. Almind K, Frederiksen SK, Bernal D, Hansen T, Ambye L, Urhammer S, Ekstrom CT, Berglund L, Reneland R, Lithell H, White MF, Van Obberghen E, and Pedersen O. Search for variants of the gene-promoter and the potential phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of their relation with alterations in insulin secretion and insulin sensitivity. Diabetologia 42: 1244-1249, 1999.
9. Almind K, Kulkarni RN, Lannon SM, and Kahn CR. Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance. Diabetes 52: 1535-1543, 2003.
10. Apfeld J and Kenyon C. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95: 199-210, 1998.
11. Araki E, Lipes MA, Patti ME, Bruning JC, Haag BR, Johnson RS, and Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190, 1994.
12. 2+ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem 275: 22331-22338, 2000.
13. Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, and Davenport ML. Effect of intravenous insulin-like growth factor I in two patients with leprechaunism. Pediatr Res 36: 749-754, 1994.
14. Baron AD. Hemodynamic actions of insulin. Am J Physiol Endocrinol Metab 267: E187-E202, 1994.
15. Baron AD, Steinberg H, Brechtel G, and Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol Endocrinol Metab 266: E248-E253, 1994.
16. Barrett CT and Oliver TK Jr. Hypoglycemia and hyperinsulinism in infants with erythroblastosis fetalis. N Engl J Med 278: 1260-1262, 1968.
17. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, and Saltiel AR. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407: 202-207, 2000.
18. Bektas A, Warram JH, White MF, Krolewski AS, and Doria A. Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes 48: 640-642, 1999.
19. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, and Abel ED. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109: 629-639, 2002.
20. Bell GI and Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414: 788-791, 2001.
21. Bernal D, Almind K, Yenush L, Ayoub M, Zhang Y, Rosshani L, Larsson C, Pedersen O, and White MF. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes 47: 976-979, 1998.
22. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling C, and Permutt M. Transgenic mice expressing a constitutively active Akt1/PKBα in pancreatic islet β-cells exhibit striking hypertrophy, hyperplasia and hyperinsulinemia. J Clin Invest 108: 1631-1638, 2001.
23. Bier DM, Schedewie H, Larner J, Olefsky J, Rubenstein A, Fiser RH, Craig JW, and Elders MJ. Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance. J Clin Endocrinol Metab 51: 988-994, 1980.
24. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK, and Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421-7426, 1999.
25. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P, and Zierath JR. Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45: 1697-1702, 2002.
26. Bluher M, Kahn BB, and Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572-574, 2003.
27. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, and Kahn CR. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25-38, 2002.
28. Bocian-Sobkowska J, Zabel M, Wozniak W, and Surdyk-Zasada J. Polyhormonal aspect of the endocrine cells of the human fetal pancreas. Histochem Cell Biol 112: 147-153, 1999.
29. Bonadonna RC, Saccomani MP, Del Prato S, Bonora E, DeFronzo RA, and Cobelli C. Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation 98: 234-241, 1998.
30. Bose A, Guilherme A, Robida SI, Nicoloro SM, Zhou QL, Jiang ZY, Pomerleau DP, and Czech MP. Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c. Nature 420: 821-824, 2002.
31. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, and Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-868, 1999.
32. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, and Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2155, 2000.
33. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, and Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569, 1998.
34. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, and Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88: 561-572, 1997.
35. Burgering BM and Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995.
36. Burks DJ, de Mora JF, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, and White MF. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407: 377-382, 2000.
37. Burks DJ and White MF. IRS proteins and beta-cell function. Diabetes 50 Suppl 1: S140-S145, 2001.
38. Cherrington Banting Lecture 1997 AD. Control of glucose uptake and release by the liver in vivo. Diabetes 48: 1198-1214, 1999.
39. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, and Saltiel AR. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410: 944-948, 2001.
40. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, 3rd Kaestner KH, Bartolomei MS, Shulman GI, and Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001.
41. Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki S, Penninger P, Doherty M, Malaisse W, Dumont J, Le Marchand-Brustel Y, Erneux C, Hue L, and Schurmans S. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409: 92-97, 2001.
42. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 140: 19-24, 1998.
43. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, and Shulman GI. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246, 1999.
44. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, and Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21: 213-215, 1999.
45. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
46. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, and Knowler WC. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 22: 944-950, 1999.
47. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, and Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J 290: 811-815, 1985.
48. Datta SR, Brunet A, and Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
49. DeBaun MR, King AA, and White N. Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatol 24: 164-171, 2000.
50. DeChiara TM, Efstratiadis A, and Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80, 1990.
51. De Fea K and Roth RA. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 36: 12939-12947, 1997.
52. Desbois-Mouthon C, Magre J, Duprey J, Caron M, Blivet-Van Eggelpoel MJ, Daubas C, Gourmelen M, Chevallier B, Rizkalla S, Robert JJ, and Capeau J. Major circadian variations of glucose homeostasis in a patient with Rabson-Mendenhall syndrome and primary insulin resistance due to a mutation (Cys284→Tyr) in the insulin receptor alpha-subunit. Pediatr Res 42: 72-77, 1997.
53. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, Gros L, and Bosch F. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105: 731-740, 2000.
54. Di Cola G, Cool MH, and Accili D. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 99: 2538-2544, 1997.
55. Duvillie B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, Monthioux E, Jami J, Joshi RL, and Bucchini D. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci USA 94: 5137-5140, 1997.
56. Economides DL, Nicolaides KH, and Campbell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 19: 97-105, 1991.
57. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 42: 955-976, 1998.
58. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, and Kennedy BP. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548, 1999.
59. Eto K, Yamashita T, Tsubamoto Y, Terauchi Y, Hirose K, Kubota N, Yamashita S, Taka J, Satoh S, Sekihara H, Tobe K, Iino M, Noda M, Kimura S, and Kadowaki T. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals. Diabetes 51: 87-97, 2002.
60. Fantin VR, Wang Q, Lienhard GE, and Keller SR. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab 278: E127-E133, 2000.
61. Fernandez A, Kim J, Yakar S, Dupont J, Hernandez-Sanchez C, Castle A, Filmore J, Shulman G, and Le Roith D. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15: 1926-1934, 2001.
62. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Baldi S, Frascerra S, Monzani F, Antonelli A, Nannipieri M, Mari A, Seghieri G, and Natali A. Insulin: new roles for an ancient hormone. Eur J Clin Invest 29: 842-852, 1999.
63. Finegood DT, Scaglia L, and Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44: 249-256, 1995.
64. Fisher SJ and Kahn CR. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest 111: 463-468, 2003.
65. Flier SN, Kulkarni RN, and Kahn CR. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci USA 98: 7475-7480, 2001.
66. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, and Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-3288, 1999.
67. Freidenberg GR, Reichart D, Olefsky JM, and Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest 82: 1398-1406, 1988.
68. Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR, and Cantley LC. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85alpha. Nat Genet 26: 379-382, 2000.
69. Frystyk J, Grofte T, Skjaerbaek C, and Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 82: 3124-3127, 1997.
70. Frystyk J, Gronbaek H, Skjaerbaek C, Flyvbjerg A, Orskov H, and Baxter RC. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats. Endocrinology 139: 4286-4292, 1998.
71. Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, and Stewart AF. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275: 1226-1232, 2000.
72. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, and Coleman KG. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112: 197-208, 2003.
73. Ghosh S and Collins FS. The geneticist's approach to complex disease. Annu Rev Med 47: 333-353, 1996.
74. Girard J, Ferre P, Pegorier JP, and Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 72: 507-562, 1992.
75. Girard JR, Kervan A, Soufflet E, and Assan R. Factors affecting the secretion of insulin and glucagon by the rat fetus. Diabetes 23: 310-317, 1973.
76. Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, Acheson K, Thiebaud D, Curchod B, Jequier E, and Felber JP. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 585-591, 1988.
77. Gottlieb S and Ruvknn G. daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics 137: 107-120, 1994.
78. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, and Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83: 69-78, 1995.
79. Guarente L, Ruvkun G, and Amasino R. Aging, life span, and senescence. Proc Natl Acad Sci USA 95: 11034-11036, 1998.
80. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, and Benito M. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108: 1205-1213, 2001.
81. Guillam MT, Hummler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, Schmidt A, Deriaz N, Thorens B, and Wu JY. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17: 327-330, 1997.
82. Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, and Rondinone CM. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52: 21-28, 2003.
83. Han VK, D'Ercole AJ, and Lund PK. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197, 1987.
84. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, and Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. Mol Cell 7: 1153-1163, 2001.
85. Havrankova J, Roth J, and Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829, 1978.
86. Hazeltine FG. Hypoglycemia and RH erythroblastosis fetalis. Pediatrics 39: 696-699, 1967.
87. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, and Vassalli JD. Embryogenesis of the murine endocrine pancreas: early expression of pancreatic polypeptide gene. Development 113: 1257-1265, 1991.
88. Hirayama I, Tamemoto H, Yokota H, Kubo SK, Wang J, Kuwano H, Nagamachi Y, Takeuchi T, and Izumi T. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes 48: 1237-1244, 1999.
89. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
90. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, and Wong AJ. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379: 560-564, 1996.
91. Hone J, Accili D, Psiachou H, Alghband ZJ, Mitton S, Wertheimer E, Sinclair L, and Taylor SI. Homozygosity for a null allele of the insulin receptor gene in a patient with leprechaunism. Hum Mutat 6: 17-22, 1995.
92. Hribal ML, Nakae J, Kitamura T, Shutter JR, and Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 162: 535-541, 2003.
93. Hribal ML, Oriente F, and Accili D. Mouse models of insulin resistance. Am J Physiol Endocrinol Metab 282: E977-E981, 2002.
94. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, and Litwin SE. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285: H1261-H1269, 2003.
95. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, and Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109: 1321-1326, 2002.
96. Isakoff SJ, Taha C, Rose E, Marcusohn J, Klip A, and Skolnik EY. The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake. Proc Natl Acad Sci USA 92: 10247-10251, 1995.
97. Jiang ZY, Chawla A, Bose A, Way M, and Czech MP. A phosphatidylinositol 3-kinase-independent insulin signaling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J Biol Chem 277: 509-515, 2002.
98. Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, Schurmann A, Seino S, and Thorens B. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 282: E974-E976, 2002.
99. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, and Bucchini D. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15: 1542-1547, 1996.
100. Jospe N, Kaplowitz PB, and Furlanetto RW. Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor. Clin Endocrinol 45: 229-235, 1996.
101. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, and Taylor SI. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787-790, 1988.
102. Kaestner KH, Knochel W, and Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142-146, 2000.
103. Kanety H, Feinstein R, Papa MZ, Hemi R, and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270: 23780-23784, 1995.
104. Katz EB, Stenbit AE, Hatton K, DePinho R, and Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151-155, 1995.
105. Kaur J, Singh P, and Sowers JR. Diabetes and cardiovascular diseases. Am J Ther 9: 510-515, 2002.
106. Kenyon C. A conserved regulatory system for aging. Cell 105: 165-168, 2001.
107. Kervran A and Girard JR. Glucose induced increase of plasma insulin in the rat fetus in utero. J Endocrinol 62: 545-551, 1974.
108. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, and Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105: 199-205, 2000.
109. Kido Y, Nakae J, and Accili D. Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 86: 972-979, 2001.
110. Kido Y, Nakae J, Hribal ML, Xuan S, Efstratiadis A, and Accili D. Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistance. J Biol Chem 277: 36740-36747, 2002.
111. Kim J and Accili D. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm IGF Res 12: 84, 2002.
112. Kim JJ, Park BC, Kido Y, and Accili D. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes. Endocrinology 142: 3354-3360, 2001.
113. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, and Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108: 437-446, 2001.
114. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Kahn CR, and Shulman GI. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105: 1791-1797, 2000.
115. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, and Shulman GI. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 108: 153-160, 2001.
116. Kimura KD, Tissenbaum HA, Liu Y, and Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946, 1997.
117. King GL and Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 227: 1583-1586, 1985.
118. Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, and Accili D. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 21: 5624-5630, 2001.
119. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, and Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19: 6286-6296, 1999.
120. Kitamura T, Nakae J, Kahn C, Efstratiadis A, and Accili D. Lipoatrophy, postnatal growth retardation and diabetes resulting from variable conditional inactivation of the insulin receptor gene in mice (Abstract). Diabetes 51 Suppl 2: 1337, 2002.
121. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH III, Wright CV, White MF, Arden KC, and Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847, 2002.
122. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, and Kahn BB. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20: 5479-5489, 2000.
123. Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA, Birnbaum MJ, Scott PH, Lawrence JC Jr, and Roth RA. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273: 11937-11943, 1998.
124. Kohn AD, Summers SA, Birnbaum MJ, and Roth RA. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996.
125. Kohn AD, Takeuchi F, and Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 271: 21920-21926, 1996.
126. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, and Kahn CR. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111: 1835-1842, 2003.
127. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, and Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634, 1999.
128. Kotani K, Ogawa W, Matsumoto M, Kitamura T, Sakaue H, Hino Y, Miyake K, Sano W, Akimoto K, Ohno S, and Kasuga M. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18: 6971-6982, 1998.
129. Krook A, Brueton L, and O'Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 342: 277-278, 1993.
130. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, and Kadowaki T. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49: 1880-1889, 2000.
131. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, and Kahn CR. Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52: 1528-1534, 2003.
132. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, and Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329-339, 1999.
133. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, and Kahn CR. Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31: 111-115, 2002.
134. Kulkarni RN, Michael MD, and Kahn CR. Tissue-specific knockouts of the insulin receptor tyrosine kinase. In: Genetic Manipulation of Receptor Expression and Function, edited by Accili D. New York: Wiley, 2000, p. 129-154.
135. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, and Kahn CR. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 104: R69-R75, 1999.
136. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, and White MF. Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109: 1193-1201, 2002.
137. Lander ES and Schork NJ. Genetic dissection of complex traits. Science 265: 2037-2048, 1994.
138. Lauro D, Kido Y, Castle AL, Zarnowski MJ, Hayashi H, Ebina Y, and Accili D. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet 20: 294-298, 1998.
139. Laustsen PG, Michael MD, Crute BE, Cohen SE, Ueki K, Kulkarni RN, Keller SR, Lienhard GE, and Kahn CR. Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev 16: 3213-3222, 2002.
140. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, and Lienhard GE. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272: 21403-21407, 1997.
141. Lavan BE, Lane WS, and Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272: 11439-11443, 1997.
142. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L, Prescott AR, Lucocq JM, and Alessi DR. Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21: 3728-3738, 2002.
143. Leahy JL and Vandekerkhove KM. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126: 1593-1598, 1990.
144. Lee SS and Ruvkun G. Longevity: don't hold your breath. Nature 418: 287-288, 2002.
145. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, and Berggren P. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 7: 559-570, 2001.
146. Leibiger IB, Leibiger B, Moede T, and Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1: 933-938, 1998.
147. Leslie NR, Biondi RM, and Alessi DR. Phosphoinositide-regulated kinases and phosphoinositide phosphatases. Chem Rev 101: 2365-2380, 2001.
148. Like AA and Orci L. Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes 21: 511-534, 1972.
149. Lin K, Dorman JB, Rodan A, and Kenyon C. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322, 1997.
150. Lin K, Hsin H, Libina N, and Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28: 139-145, 2001.
151. Liu JP, Baker J, Perkins AS, Robertson EJ, and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993.
152. Liu SCH, Wang Q, Lienhard GE, and Keller SR. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 274: 18093-18099, 1999.
153. Longo N, Wang Y, and Pasquali M. Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 84: 2623-2629, 1999.
154. Louvi A, Accili D, and Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189: 33-48, 1997.
155. Lowell BB, SSV, Hamann A, Lawitts JA, Himms HJ, Boyer BB, Kozak LP, and Flier JS. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740-742, 1993.
156. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, and Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177: 517-535, 1996.
157. Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, D'Ercole AJ, and Van Wyk JJ. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261: 14539-14544, 1986.
158. Marin P, Hogh-Kristiansen I, Jansson S, Krotkiewski M, Holm G, and Bjorntorp P. Uptake of glucose carbon in muscle glycogen and adipose tissue triglycerides in vivo in humans. Am J Physiol Endocrinol Metab 263: E473-E480, 1992.
159. Matschinsky Banting Lecture 1995 FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45: 223-241, 1996.
160. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, and Kahn CR. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 109: 141-149, 2002.
161. Mc Evoy RC and Madson KL. Pancreatic insulin-, glucagon-, and somatostatin-positive islets cell populations during the perinatal development of the rat. II. Changes in hormone content and concentration. Biol Neonate 38: 255-259, 1980.
162. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, and Kahn CR. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6: 87-97, 2000.
163. Miki H, Yamauchi T, Suzuki R, Komeda K, Tsuchida A, Kubota N, Terauchi Y, Kamon J, Kaburagi Y, Matsui J, Akanuma Y, Nagai R, Kimura S, Tobe K, and Kadowaki T. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol Cell Biol 21: 2521-2532, 2001.
164. Morris JZ, Tissenbaum HA, and Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382: 536-539, 1996.
165. Mu J, Brozinick JT Jr, Valladares O, Bucan M, and Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
166. Najjar SM, Blakesley VA, Li Calzi S, Kato H, LeRoith D, and Choice CV. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 36: 6827-6834, 1997.
167. Najjar SM, Philippe N, Suzuki Y, Ignacio GA, Formisano P, Accili D, and Taylor SI. Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34: 9341-9349, 1995.
168. Nakae J, Barr V, and Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 19: 989-996, 2000.
169. Nakae J, Biggs WH, Kitamura T, Cavenee WK, Wright CV, Arden KC, and Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32: 245-253, 2002.
170. Nakae J, Kido Y, and Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22: 818-835, 2001.
171. Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC, and Accili D. The forkhead transcription factor foxo1 regulates adipocyte differentiation. Dev Cell 4: 119-129, 2003.
172. Nakae J, Kitamura T, Silver DL, and Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: 1359-1367, 2001.
173. Nakae J, Park BC, and Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J Biol Chem 274: 15982-15985, 1999.
174. Obici S, Feng Z, Karkanias G, Baskin DG, and Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5: 566-572, 2002.
175. Obici S, Zhang BB, Karkanias G, and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382, 2002.
176. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, and Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999, 1997.
177. Olefsky JM, Kolterman OG, and Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol Endocrinol Metab 243: E15-E30, 1982.
178. Paradis S and Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12: 2488-2498, 1998.
179. Park BC, Kido Y, and Accili D. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry 38: 7517-7523, 1999.
180. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272: 29911-29918, 1997.
181. Pendergrass M, Fazioni E, and DeFronzo RA. Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diabetes Rev 3: 566-583, 1996.
182. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, and Hay N. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365, 2003.
183. Polak M, Bouchareb-Banaei L, Scharfmann R, and Czernichow P. Early pattern of differentiation in the human pancreas. Diabetes 49: 225-232, 2000.
184. Polonsky KS, Sturis J, and Bell GI. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334: 777-783, 1996.
185. Postic C and Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26: 149-150, 2000.
186. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, and Magnuson MA. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315, 1999.
187. Poy MN, Yang Y, Rezaei K, Fernstrom MA, Lee AD, Kido Y, Erickson SK, and Najjar SM. CEACAM1 regulates insulin clearance in liver. Nat Genet 30: 270-276, 2002.
188. Previs SF, Withers DJ, Ren JM, White MF, and Shulman GI. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275: 38990-38994, 2000.
189. Psiachou H, Mitton S, Alaghband ZJ, Hone J, Taylor SI, and Sinclair L. Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 342: 924, 1993.
190. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, and Spiegelman BM. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423: 550-555, 2003.
191. Rall LB, Pictet RL, and Rutter WJ. Synthesis and accumulation of proinsulin and insulin during development of the embryonic rat pancreas. Endocrinology 105: 835-841, 1979.
192. Reinecke-Luthge A, Koschoreck F, and Kloppel G. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Arch 436: 1-5, 2000.
193. Roach P, Zick Y, Formisano P, Accili D, Taylor SI, and Gorden P. A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43: 1096-1102, 1994.
194. Rordorf NT, Van HD, Chen D, White MF, and Backer JM. Regulation of phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem 270: 3662-3666, 1995.
195. Rosen ED, Walkey CJ, Puigserver P, and Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307, 2000.
196. Rossetti L, Lee YT, Ruiz J, Aldridge SC, Shamoon H, and Boden G. Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol Endocrinol Metab 265: E761-E769, 1993.
197. Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, and Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 273: 17491-17497, 1998.
198. Roysarkar TK, Gupta A, Dash RJ, and Dogra MR. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus. Am J Ophthalmol 115: 569-574, 1993.
199. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, and White MF. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
200. Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, Spiegelman BM, and Kasuga M. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273: 28945-28952, 1998.
201. Saltiel AR and Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
202. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders T, Bonner-Weir S, and Kaufman RJ. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7: 1165-1176, 2001.
203. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
204. Sciacchitano S and Taylor SI. Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology 138: 4931-4940, 1997.
205. She P, Shiota M, Shelton KD, Chalkley R, Postic C, and Magnuson MA. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 20: 6508-6517, 2000.
206. Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, and Sampson SR. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. Am J Physiol Endocrinol Metab 281: E16-E24, 2001.
207. Shier P and Watt VM. Primary structure of a putative receptor for a ligand of the insulin family. J Biol Chem 264: 14605-14608, 1989.
208. Shimizu Y and Shimazu T. Effects of wortmannin on increased glucose transport by insulin and norepinephrine in primary culture of brown adipocytes. Biochem Biophys Res Commun 202: 660-665, 1994.
209. Shiojima I, Yefremashvili M, Luo Z, Kureishi Y, Takahashi A, Tao J, Rosenzweig A, Kahn CR, Abel ED, and Walsh K. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 277: 37670-37677, 2002.
210. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, and Schlessinger J. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260: 1953-1955, 1993.
211. Smith-Hall J, Pons S, Patti ME, Burks DJ, Yenush L, Sun XJ, Kahn CR, and White MF. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36: 8304-8310, 1997.
212. Standaert ML, Bandyopadhyay G, Galloway L, Soto J, Ono Y, Kikkawa U, Farese RV, and Leitges M. Effects of knockout of the protein kinase C beta gene on glucose transport and glucose homeostasis. Endocrinology 140: 4470-4477, 1999.
213. Stefan Y, Ravazzola M, and Orci L. Primitive islets contain two populations of cells with differing glucagon immunoreactivity. Diabetes 30: 192-195, 1981.
214. Steil GM, Ader M, Moore DM, Rebrin K, and Bergman RN. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest 97: 1497-1503, 1996.
215. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, Houseknecht K, Katz EB, and Charron MJ. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3: 1096-1101, 1997.
216. San XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, and White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77, 1991.
217. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MJ, Glasheen E, Lane WS, Pierce JH, and White MF. Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173-177, 1995.
218. Takahashi Y, Kadowaki H, Momomura K, Fukushima Y, Orban T, Okai T, Taketani Y, Akanuma Y, Yazaki Y, and Kadowaki T. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia 40: 412-420, 1997.
219. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, and Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186, 1994.
220. Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41: 1473-1490, 1992.
221. Taylor SI, Hedo JA, Underhill LH, Kasuga M, Elders MJ, and Roth J. Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor. J Clin Endocrinol Metab 55: 1108-1113, 1982.
222. Terauchi Y, Matsui J, Suzuki R, Kubota N, Komeda K, Aizawa S, Eto K, Kimura S, Nagai R, Tobe K, Lienhard GE, and Kadowaki T. Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice. J Biol Chem 278: 14284-14290, 2003.
223. Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, Ito K, Kasai H, Suzuki H, Ueda O, Kamada N, Jishage K, Komeda K, Noda M, Kanazawa Y, Taniguchi S, Miwa I, Akanuma Y, Kodama T, Yazaki Y, and Kadowaki T. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem 270: 30253-30256, 1995.
224. Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, Okuno A, Inukai K, Asano T, Kaburagi Y, Ueki K, Nakajima H, Hanafusa T, Matsuzawa Y, Sekihara H, Yin Y, Barrett JC, Oda H, Ishikawa T, Akanuma Y, Komuro I, Suzuki M, Yamamura K, Kodama T, Suzuki H, and Kadowaki T. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet 21: 230-235, 1999.
225. a. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342: 381-389, 2000.
226. b. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
227. Tian R and Abel ED. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103: 2961-2966, 2001.
228. Tissenbaum HA and Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148: 703-717, 1998.
229. Tong P, Khayat ZA, Huang C, Patel N, Ueyama A, and Klip A. Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffies. J Clin Invest 108: 371-381, 2001.
230. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, and Birnbaum MJ. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7: 1133-1137, 2001.
231. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am 23: 221-241, 1996.
232. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, and Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756-761, 1985.
233. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, and Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503-2512, 1986.
234. Vanhaesebroeck B and Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576, 2000.
235. Vasavada R, Garcia-Ocana A, Zawalich W, Dann P, Sorenson R, Ogren L, Talamantes F, and Stewart A. Expression of placental lactogen in the islets of transgenic mice results in accelerated beta cell proliferation, islet mass augmentation and hypoglycemia. Diabetes 48 Suppl 1: 245, 1999.
236. Vasavada RC, Garcia-Ocana A, Zawalich WS, Sorenson RL, Dann P, Syed M, Ogren L, Talamantes F, and Stewart AF. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275: 15399-15406, 2000.
237. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, and Kahn CR. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111: 1373-1380, 2003.
238. Wertheimer E, Lu SP, Baekeljauw PF, Davenport ML, and Taylor SI. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 5: 71-73, 1993.
239. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin and interleukin signalling. Mol Cell Biochem 182: 3-11, 1998.
240. Widdowson EM. Chemical composition of newly born mammals. Nature 166: 626-628, 1950.
241. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, and White MF. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nature Genet 23: 32-40, 1999.
242. Withers DJ, Sanchez-Gutierrez J, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, and White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904, 1998.
243. Wojtaszewski JF, Higaki Y, Hirshman MF, Michael MD, Dufresne SD, Kahn CR, and Goodyear LJ. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 104: 1257-1264, 1999.
244. Xu P, Jacobs AR, and Taylor SI. Interaction of insulin receptor substrate 3 with insulin receptor, insulin receptor-related receptor, insulin-like growth factor-1 receptor, and downstream signaling proteins. J Biol Chem 274: 15262-15270, 1999.
245. Xuan S, Kitamura T, Nakae J, Politi K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, and Efstratiadis A. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest 110: 1011-1019, 2002.
246. Yang C, Coker KJ, Kim JK, Mora S, Thurmond DC, Davis AC, Yang B, Williamson RA, Shulman GI, and Pessin JE. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest 107: 1311-1318, 2001.
247. Yang YJ, Hope ID, Ader M, and Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84: 1620-1628, 1989.
248. Yoshinari M and Daikoku S. Ontogenetic appearance of immunoreactive endocrine cells in rat pancreatic islets. Anat Embryol 165: 63-70, 1982.
249. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
250. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, and Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673-1677, 2001.
251. Zawalich WS and Zawalich KC. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 141: 3287-3295, 2000.
252. Zhao AZ, Zhao H, Teague J, Fujimoto W, and Beavo JA. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci USA 94: 3223-3228, 1997.
253. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhanot S, Monia BP, and Jirousek MR. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99: 11357-11362, 2002.
254. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, and Kahn BB. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6: 924-928, 2000.